1. Blocking the inflammasome: A novel approach to treat uveitis
- Author
-
Ilva D. Rupenthal, Rachael L Niederer, Odunayo O Mugisho, and Avik Shome
- Subjects
Pharmacology ,Inflammation ,business.industry ,Inflammasomes ,Inflammasome ,Disease ,medicine.disease ,Models, Biological ,Autoimmune Diseases ,Uveitis ,Infectious uveitis ,Drug Development ,Infectious disease (medical specialty) ,Drug Discovery ,Immunology ,medicine ,Etiology ,Effective treatment ,Animals ,Humans ,medicine.symptom ,business ,medicine.drug - Abstract
Uveitis is a complex ocular inflammatory disease often accompanied by bacterial or viral infections (infectious uveitis) or underlying autoimmune diseases (non-infectious uveitis). Treatment of the underlying infection along with corticosteroid-mediated suppression of acute inflammation usually resolves infectious uveitis. However, to develop more effective therapies for non-infectious uveitis and to better address acute inflammation in infectious disease, an improved understanding of the underlying inflammatory pathways is needed. In this review, we discuss the disease aetiology, preclinical in vitro and in vivo uveitis models, the role of inflammatory pathways, as well as current and future therapies. In particular, we highlight the involvement of the inflammasome in the development of non-infectious uveitis and how it could be a future target for effective treatment of the disease.
- Published
- 2021